Cancer Screening & Hematology: Patient-Centered Clinical Care of African Americans Episode 4: Bridging the Gap: Conversations with Dr. Hall
This session will provide an overview of the differences in the prevention and screening for select cancers (colon, prostate, breast, and lung) in African Americans. Discussion will focus on differences in the interpretation of common laboratory results including TSH, CBC, and others based on population outcome data.
Episode 6: Coffee with Chopra
Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.
When is a nosebleed not a normal nosebleed? How much menstrual bleeding is too much? Hemophilia is the best-known bleeding disorder and perhaps the most severe, but there are other milder diseases like von Willebrand disease that are much more common. What are the common myths and perceptions about children with disorders of coagulation? What does the general pediatrician need to know about bleeding disorders? The speaker will cover the basics of identifying children with abnormal bleeding and managing their conditions effectively.
The goal of this activity is to understand the challenges of individualized management of CKD-related anemia with a focus on strategies for making treatment decisions and patient-centric treatment plans. Unmet needs of treating anemia of CKD will also be discussed.
This lecture will discuss the appropriate follow-up of patients treated for the most common cancers. This will include breast cancer, colorectal cancer, Hodgkin's and non-Hodgkin's lymphoma, prostate cancer, and lung cancer. An in-depth discussion of the physical challenges and psychological impacts of a cancer diagnosis and its treatment will prepare you to help your patients with what lies ahead.
The early detection of cancer can significantly improve the treatment and outcomes for patients. Screening is an effective tool for early detection, but emerging evidence constantly shift these recommendations. This case-based presentation will focus on the most recent guidelines from the leading agencies including ACS, NCCN, and USPSTF and discuss strategies on how to apply them to your patients.
This presentation will provide background on the epidemiology of cancer survivorship and focus on the growing numbers of individuals with a history of cancer who are in primary care clinical practice. Dr. Ganz will discuss the common long-term and late effects of cancer treatment and what kind of follow-up care patients need, including the important role primary care providers (PCPs) can play in health promotion and disease prevention. The talk will emphasize the importance of collaboration between oncologists and PCPs in the follow-up care of cancer survivors. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 9/10/2020, and they are subject to change as new information is published.